Upadacitinib Versus Tofacitinib in Anti‐ MDA5 ‐Positive Dermatomyositis With Interstitial Lung Disease: A Multi‐Centre Cohort Study Emulating a Target Trial

Ähnliche Einträge

• The FLATCAN Model: A Novel Score for Predicting Mortality Risk in Anti‐Melanoma Differentiation‐Associated Gene 5‐Positive Dermatomyositis
  von: Chen Zong, et al.
  Veröffentlicht: (2025)
• Fenestrated vs. Conventional Silicone Stents in Benign Central Airway Stenosis: Clinical Outcomes and Biomechanical Validation
  von: Qixia Wang, et al.
  Veröffentlicht: (2025)
• The Assessment of Subglottic and Cervical Tracheal Stenosis Using a Novel Point‐of‐Care Ultrasound Method: Measurement of Tracheal Radius Curvature
  von: Jieru Lin, et al.
  Veröffentlicht: (2025)
• The potential lipid biomarker 5‐HETE for acute exacerbation identified by metabolomics in patients with idiopathic pulmonary fibrosis
  von: Yichao Zhao, et al.
  Veröffentlicht: (2024)
• Safety and efficacy of a novel transbronchial radiofrequency ablation system for lung tumours: One year follow‐up from the first multi‐centre large‐scale clinical trial ( BRONC ‐ RFII )
  von: Changhao Zhong, et al.
  Veröffentlicht: (2024)